HY Asiakirjapohja
Total Page:16
File Type:pdf, Size:1020Kb
BOARD MEETING 4/2013 24 October 2013 MINUTES INSTITUTE FOR MOLECULAR MEDICINE FINLAND FIMM Nordic EMBL Partnership for Molecular Medicine Title: Meeting of the Board of FIMM 4/2013 Time: Thursday, 24 October 2013, at 14.00—15.35 Place: FIMM Meeting Room D307a, Biomedicum Helsinki 2U, Tukholmankatu 8, Helsinki Chair: Vice Rector, Professor Kimmo Kontula, University of Helsinki Members (Deputy Members): Professor Kalle Saksela, Haartman Institute, Faculty of Medicine, University of Helsinki Professor Kimmo Porkka, Institute of Clinical Medicine, Faculty of Medicine, University of Helsinki; left in item 4.11 Professor Annamari Ranki, Institute of Clinical Medicine, Faculty of Medicine, University of Helsinki; arrived in item 4.11 Chief Research Officer, Professor Lasse Viinikka, HUS Senior Scientist, Head of Public Health Genomics Unit Anu Jalanko, THL Vice President, Professor, R&D Biotechnology Anu Kaukovirta-Norja, VTT CEO Saara Hassinen, Strategic Centre for Health and Well-being, SalWe Oy Director, Professor Eero Vuorio, Biocenter Finland Head of Laboratory Pekka Ellonen, FIMM Technology Centre Experts: Financial Manager Marja Medina, FIMM Head of Development Kimmo Pitkänen, FIMM Presenter: Director, Professor Olli Kallioniemi, FIMM Secretary: Administrative Manager Reetta Niemelä, FIMM 2(15) INSTITUTE FOR MOLECULAR MEDICINE FINLAND FIMM Nordic EMBL Partnership for Molecular Medicine Meeting of the Board of FIMM 4/2013 1 Opening of the meeting and presence of a quorum 2 Approval of the agenda 3 Approval of the minutes of the previous meetings 4 Announcements 5 FIMM budget plan for 2014 and update of the Target Programme 6 Evaluation of suggested collaboration between FIMM/University of Helsinki and VTT in the field of metabolomics 7 The term of the current Board of FIMM 8 Other business 9 Date of the next meeting 10 Closing of the meeting 3(15) INSTITUTE FOR MOLECULAR MEDICINE FINLAND FIMM Nordic EMBL Partnership for Molecular Medicine 1 Opening of the meeting and presence of a quorum Proposal: It was proposed that a quorum be present when the Chair of the meeting as well as at least half of the other members are present (FIMM Regulations 5 §). Decision: It was recorded that a quorum was present. 2 Approval of the agenda Proposal: It was proposed that the agenda be approved. Decision: As proposed. 3 Approval of the minutes of the previous meetings Proposal: 1. It was proposed that the minutes of the previous meeting held on 5 June 2013 is approved (Annex 1). 2. It was proposed that the minutes of the email meeting of 30 September 2013 is approved (Annex 2). Decision: 1. As proposed. 2. As proposed. 4 Announcements 4.1 The FIMM 5-year Evaluation was carried out in May 2013. The Evaluation Report signed by Evaluation Committee Members is in Annex 3a. The public part of the Evaluation Report is available at http://www.fimm.fi/en/news/the_5-year_evaluation_report_of_fimm/. The Evalua- tion Report has been sent to FIMM stakeholders, including EMBL. The Director General of EMBL, Professor Iain Mattaj has introduced the Report and given a positive summary of FIMM progress at the EMBL Council Meeting in June 2013. The signed statement of the Board of FIMM on those group leaders whose five-year term is ending in 2013—2014 is in Annex 3b. 4.2 The Board of the University of Helsinki selected Professor Jukka Kola the new Rector on 12 June 2013 and he started his five-year term on 1 August 2013 (http://www.helsinki.fi/administration/rector/index.html). The Board of the University decided on the Vice Rectors on 16 October 2013 as proposed by Rector Jukka Kola as follows: . Professor Keijo Hämäläinen, Dean of the Faculty of Science (responsible e.g. for educa- tion, research and innovation affairs, research infrastructures and collaboration with state research institutes) . Professor Anna Mauranen, Dean of the Faculty of Arts (responsible e.g. for international af- fairs and societal interaction) . Professor Pertti Panula, Vice Director of the Institute of Biomedicine and holder of a Swe- dish-speaking professorship (responsible e.g. for societal interaction, especially Nordic col- laboration and collaboration with HUS) 4(15) INSTITUTE FOR MOLECULAR MEDICINE FINLAND FIMM Nordic EMBL Partnership for Molecular Medicine 4.3 The first meeting with Rector Jukka Kola, the Directorship of the University of Helsinki and Di- rectors of the independent institutes of the University was held on 15 October 2013. The struc- tural development of the University was discussed and the Rector encouraged the independent institutes and faculties to be proactive and discuss joint initiatives in various activities. 4.4 Translational Medicine ESFRI infrastructure EATRIS has been established as a European Research Infrastructure Consortium (ERIC). Government's letter of 6 June 2013 regarding Finland's accession to the European Infrastructure for Translational Medicine (Valtioneu- voston kirjelmä eduskunnalle Suomen liittymisestä eurooppalaiseen translationaalisen lääketieteen tutkimusinfrastruktuurikonsortioon, EATRIS ERIC –konsortioon liittyminen) is in Annex 4. EATRIS Constitutional Meeting will be arranged on 18—19 November 2013 in the Hague, the Netherlands, hosted by the Ministry of Education, Culture and Science. EATRIS is the first biomedical ESFRI to be approved as an ERIC. 4.5 In April 2013 the Academy of Finland FIRI expert group delivered to the Ministry of Education and Culture a recommendation for Finland to join the ERICs of EATRIS and BBMRI. The final BBMRI ERIC application was submitted to the European Commission in late May. Preparations for Finland to join BBMRI ERIC are underway. Olli Kallioniemi has been invited to and expert consultation of the Constitutional Law Committee of the Parliament of Finland on 22 Octo- ber 2013 (Asiantuntijakuuleminen eduskunnan sivistysvaliokunnassa; U 62/2013 vp Su- omen liittymisestä eurooppalaiseen biopankkeja ja biologisia aineistoja koskevaan tutki- musinfrastruktuurikonsortioon, BBMRI-ERIC -konsortioon liittyminen). On 11 September 2013 Olli Kallioniemi participated in a panel discussion regarding biobanks in the Parliament of Finland. 4.6 Bioinformatics ESFRI infrastructure ELIXIR is in the process of being formally established as EMBL Special Project legal entity with UK, Sweden and EMBL having signed the Consortium Agreement (ECA). More countries including Finland are expected to join before the end of the year. Meanwhile the construction of the ELIXIR building has been completed at the Genome Campus in Hinxton, UK. 4.7 The Academy of Finland is updating the national roadmap for research infrastructures in 2013. The submission deadline of the stage 1 proposals was in February and stage 2 proposals in May 2013. The roadmap decision has been made by the Academy of Finland on 3 October 2013. Academy of Finland has also made a decision to have the roadmap approved by the Research and Innovation Council (Tutkimus- ja innovaationeuvosto, TIN). The next meeting of the Council is in mid-November. 4.8 The deadline of the research infrastructure call FIRI 2013 of the Academy of Finland was on 31 May 2013. According to the call text the Academy was prepared to fund research infrastruc- tures with 15 M€. Based on information of the Academy of Finland (http://www.aka.fi/en- GB/A/Academy-of-Finland/Media-services/Releases1/Academy-of-Finland-allocates-EUR-20- million-to-research-aimed-at-boosting-economic-growth/), the Board has decided to allocate 20 M€ to facilitate cutting-edge research and to launch two thematic research programmes. The appropriations are included in the Government’s third supplementary budget proposal for 2013. Of the funding, a total of 12 M€ will be used to support Centres of Excellence and research in- frastructures that are of key importance to Finland. FIRI-2013 decisions are expected by the end of November. 5(15) INSTITUTE FOR MOLECULAR MEDICINE FINLAND FIMM Nordic EMBL Partnership for Molecular Medicine The FIRI funding is intended to support the construction of a new research infrastructure or the significant upgrading of an existing infrastructure. The funding is primarily allocated to invest- ment costs at the construction phase of infrastructures and to significant upgrading of existing infrastructures. 4.9 Biocenter Finland (BF) Technology Platform funding decision for 2014—2016 has been made at the University of Helsinki (decisions have not been made in all Biocenter Universities yet). FIMM has been granted 683 000 € for 2014 for the following Technology Platforms: Bioinfor- matics, Genome-Wide Methods, Metabolomics, Translational Technologies (Biobank and Drug discovery and chemical biology) and Viral Gene Transfer & Cell Therapy. BF was searching for Director for the period of 1 January 2014—31 December 2016. The Rec- tors of the Biocenter Universities have appointed Professor Eero Vuorio the Director from 1 January 2014 to 31 December 2014, as he is available only for this one-year period. The Board of BF has set up a Search Committee to prepare a new call and to identify potential Direc- tor candidates. The new Director shall be appointed as of 1 January 2015. 4.10 The Ministry of Social Affairs and Health has sent a request for a statement to FIMM on the draft statute of the biobank consent document of the Finnish Government and the draft statute of the biobank communication of the Ministry of Social Affairs and Health (STM065:01/2012, 21.5.2013, Lausuntopyyntö luonnoksista valtioneuvoston asetukseksi bi- opankin suostumusasiakirjasta ja sosiaali- ja terveysministeriön asetukseksi biopankin tie- donannosta 5.7.2013 mennessä). FIMM statement in Annex 5a. In addition, FIMM has given a statement on the draft statute on the charges of the regional ethics committee and the National Committee on Medical Research Ethics TUKIJA opinions (Lausunto luonnoksesta asetukseksi alueellisen eettisen toimikunnan ja valtakun- nallisen lääketieteellisen tutkimuseettisen toimikunnan lausunnoista perittävistä maksuis- ta). FIMM statement in Annex 5b. 4.11 The research project "Helsinki Urological Biobank HUB" filed a request to National Committee on Medical Research Ethics TUKIJA for an ethical opinion regarding registration of HUB as an official biobank.